Currently, the National Center for Gender Equity and Reproductive Health within the MOH is responsible for NBS policies and the screening panel includes CH, CAH, PKU, GALT, CF, and G6PD [1232]. This evidence concerns the gene G6PD and cyclic hematopoiesis.